Concepedia

Philip S. Portoghese

PS

Statistics

Publications

237

Citations

15.2K

H-Index

64

Active since

1961

Affiliations

University of Minnesota(Current)

Institute of Medicinal Plant Development

Twin Cities Orthopedics

University of Minnesota Medical Center

Philip S. Portoghese is an author at University of Minnesota specializing in pharmacology, medicine, and opioid pharmacology.

Publications per year

1961–2019

237

Publications

237

Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist

Philip S. Portoghese, Marjia Sultana, A.E. Takemori · European Journal of Pharmacology · 1988 · 613 citations

, , +10

Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonists

Philip S. Portoghese, A. W. Lipkowski, A.E. Takemori · Life Sciences · 1987 · 533 citations

, , +10

Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats

Stephen D. Mague, Andrea M. Pliakas, Mark S. Todtenkopf et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 480 citations

, , +17

Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.

Essam E. Abdelhamid, Marjia Sultana, Philip S. Portoghese et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 427 citations

, , +16

Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.

A.E. Takemori, Begonia Y. Ho, J S Naeseth et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 411 citations

, , +16

1–5 of 237